Lantheus Holdings Inc.

11/11/2024 | Press release | Distributed by Public on 11/11/2024 06:48

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025